Has Patrick McEneaney received payments from drug or device companies?

Yes. Drug and device makers reported $585,566 in general payments to Patrick McEneaney across 528 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patrick McEneaney did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patrick McEneaney come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patrick McEneaney

Foot & Ankle Surgery · Cary, ILNPI 1174613319

Payments from drug & device makers

$585,566in general payments, 2019–2025

Across 528 payments — averaging $1109.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kerecis Limited$191K
Johnson & Johnson$120K
Medshape, Inc.$115K
Crossroads Extremity Systems, LLC$68K
Innovation Technologies Inc$24K
Biotissue Holdings Inc.$15K
plus $53K from 54 others

$21,131in research payments, 2019–2025

Across 4 payments — averaging $5282.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Kerecis Limited$20K
Innovation Technologies Inc$2K

What the payments were for

Royalty or licence$182,42832%
Consulting fees$58,95910%
Speaking & faculty fees$108,15019%
Grants$15,0003%
Travel & lodging$20,4124%
Food & beverage$34,7386%
Education$10,0132%
Entertainment$3290%
Charitable contribution$25,0004%
Other$115,04320%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kerecis Limited	84	$190,715
Johnson & Johnson(2 entities)	27	$119,597
Medshape, Inc.	5	$115,391
Crossroads Extremity Systems, LLC	23	$67,832
Innovation Technologies Inc	10	$23,647
Biotissue Holdings Inc.	3	$15,143
Stryker(2 entities)	147	$14,402
Biocomposites Inc	27	$12,445
Synthes USA Products LLC	4	$8,190
Medline Industries LP	7	$4,437
Surgenex LLC	15	$1,629
In2bones USA, LLC	2	$1,513
Restor3d, Inc.	2	$1,125
Treace Medical Concepts, Inc.	13	$693
Anika Therapeutics, Inc.	8	$621
Amniox Medical, Inc.	3	$547
Smith+Nephew	7	$474
Dunamis Medical, LLC	2	$394
Zimmer Biomet	13	$382
Medela LLC	5	$374
Ortho Solutions Inc	3	$360
Osteomed LLC	7	$354
Linvatec Corporation	4	$351
Abbott	4	$348
Musculoskeletal Transplant Foundation Inc.	4	$340
Acera Surgical, Inc.	8	$288
Medtronic	3	$267
Aroa Biosurgery Incorporated	4	$222
Axogen	3	$219
Bone Support Inc.	5	$201
Miach Orthopaedics, Inc.	1	$183
Fusion Orthopedics USA, LLC	7	$176
Organogenesis Inc.	3	$167
Paratek Pharmaceuticals, Inc.	8	$148
Ossdsign USA Incorporated	1	$146
Celularity Inc.	2	$146
Nevro Corp.	2	$129
Misonix Inc	4	$129
Melinta Therapeutics, LLC	1	$125
Flower Orthopedics Coporation	2	$124
Integra Lifesciences Corporation	3	$122
Reapplix Inc.	1	$119
Encore Medical, LP	2	$112
Baudax Bio Inc.	1	$108
Osiris Therapeutics Inc.	1	$108
Amgen(2 entities)	5	$102
Orthofix Medical, Inc.	4	$92
Paragon 28, Inc.	3	$90
Globus Medical	1	$90
Acumed LLC	2	$86
DJO, LLC	2	$63
Trice Medical, Inc.	1	$59
Vaporox, Inc.	1	$54
Next Science LLC	2	$49
Fidia Pharma USA Inc.	2	$40
Heron Therapeutics, Inc.	2	$40
KCI USA, Inc.	2	$40
Urgo Medical North America, LLC	1	$37
Bioventus LLC	1	$30
ETS Wound Care LLC	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$585,566 in reported general payments places this provider in the 95th percentile of 555 foot & ankle surgery providers in Illinois.

See all foot & ankle surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$172,121

Medicare patients

344

Services billed

1,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	34	$324
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	22	$214
Gabapentin	28	$203
Terbinafine Hcl	11	$93

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Cary

Peter LovatoCary$162K
Douglas PacaccioRockford$4.3M
Anand VoraLibertyville$3.2M
Lowell WeilMount Prospect$2.4M
Matthew SorensenAlgonquin$1.1M
Edgardo Rodriguez CollazoChicago$755K
David GarrasOrland Park$658K
Brian BurgessNaperville$496K
Kyle PearsonMorris$208K
Stephanie OexemanChicago$206K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →